Diagnosing and treating depression in patients with Parkinson's disease

Psychiatric Annals

Volumn 34, Issue 4, 2004, Pages 298-304

  Weintraub, Daniel ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GlaxoSmithKline ^*  (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NORADRENALIN; NORTRIPTYLINE; PLACEBO; SELEGILINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ACETYLCHOLINE RELEASE; BEHAVIOR THERAPY; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOPAMINE RELEASE; DOSE CALCULATION; DRUG EFFECT; GERIATRIC PATIENT; HUMAN; MAJOR DEPRESSION; MEDICAL ASSESSMENT; NEUROBIOLOGY; NORADRENALIN RELEASE; PARKINSON DISEASE; PSYCHOLOGIC ASSESSMENT; RATING SCALE; REVIEW; SCORING SYSTEM; SEROTONIN RELEASE;

EID: 2342422087     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20040401-10     Document Type: Review

References (41)

1. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol. 1995;142(8):820-827.
2. Parkinson J. An Essay on the Shaking Palsy. London, England: Sherwood, Neely and Jones; 1817.
3. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatrie disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67(4):492-496.
4. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2002;8(3):193-197.
5. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG. Depression in Parkinson's disease. J Nerv Ment Disease. 1990;178(1):27-31.
6. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's Disease. A community-based study. Arch Neurol 1996;53(2):175-179.
7. Cole SA, Woodard JL, Juncos JL, et al. Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1996;8(1):20-25.
8. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings JL. Risk factors for depression in Parkinson disease. Arch Neurol. 1997;54(5):625-630.
9. Menza MA, Sage J, Marshall E, Cody R, Duvoisin R. Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord. 1990;5(2):148-151.
10. Rektorova I, Rektor I, Bares M, et al. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol. 2003;10(4):399-406.
11. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med. 1999;340(19):1476-1480.
12. Houeto JL, Mesnage V, Mallet L, et al. Behavioral disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2002;72(6):701-707.
13. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Impact of psychiatric and other non-motor symptoms on disability in Parkinson's disease. J Am Geriatr Soc. In press.
14. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000;69(3):308-312.
15. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's Disease: a population-based, prospective study. J Am Geriatr Soc. 2000;48(8):938-942.
16. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55(5):377-382.
17. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord. 2000;15(4):669-677.
18. Schuurman AG, van den Akker M, Ensinck KT, et al. Increased risk of Parkinson's disease after depression. Neurology. 2002;58(10):1501-1504.
19. Hoogendijk WJ, Sommer IE, Tissingh G, Deeg DJ, Wolters EC. Depression in Parkinson's disease: the impact of symptom overlap on prevalence. Psychosomatics. 1998;39(5):416-421.
20. Leentjens AF, Verhey FR, Luijckx GJ, Troost J. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord. 2000;15(6):1221-1224.
21. Wermuth L, Sørensen PS, Timm S, et al. Depression in idiopathic Parkinson's disease treated with citalopram: a placebo-controlled trial. Nord J Psychiatry. 1998;52(2):163-169.
22. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol. 2003;16(3):178-183.
23. Pitcairn TK, Clemie S, Gray JM, Pentland B. Impressions of parkinsonian patients from their recorded voices. Br J Disord Commun. 1990;25(1):85-92.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Publishing Inc; 1994.
25. Andersen J, Aabro E, Gulmann N, Hjelmsted A, Pedersen HE. Anti-depressive treatment in Parkinson's disease: a controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with 1-dopa. Acta Neurol Scand. 1980;62(4):210-219.
26. Leentjens AF, Vreeling FW, Luijckx GJ, Verhey FR. SSRIs in the treatment of depression in Parkinson's disease. Int J Geriatr Psychiatry. 2003;18(6):552-554.
27. Treatment of depression in idiopathic Parkinson's disease. Mov Disord. 2002;17(Suppl 4):S112-S119.
28. van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. Br J Clin Pharmacol. 2003;54(2):168-170.
29. Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint. In: Behavioral Neurology of Movement Disorders. Weiner WJ, Lang AE, eds. New York, NY: Raven Press; 1995.
30. Cantello R, Aguggia M, Gilli M, et al. Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse. J Neurol Neurosurg Psychiatry. 1989;52(6):724-731.
31. Mössner R, Henneberg A, Schmitt A, et al. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry. 2001;6(3):350-352.
32. Levin BE, Katzen HL. Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. In: Behavioral Neurology of Movement Disorders. Weiner WJ, Lang AE, eds. New York, NY: Raven Press; 1995.
33. Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE. Cognitive functions in major depression and Parkinson disease. Arch Neurol. 1997;54(8):982-986.
34. Tröster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol. 1995;52(12):1164-1169.
35. Alexopoulos GS. "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? Am J Geriatr Psychiatry. 2001;9(1):22-29.
36. Marder K, Tang MX, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol. 1995;52(7):695-701.
37. Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease. Arch Neurol. 1999;56(5):595-601.
38. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry. 1993;34(7):465-470.
39. Starkstein SE, Mayberg HS, Preziosi TJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134-139.
40. Lou JS, Kearns G, Oken B, Sexton G, Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord. 2001;16(2):190-196.
41. Caap-Ahlgren M, Dehlin O. Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview of patients living at home. Arch Gerontol Geriatr. 2001;32(1):23-33.